NCT03107169View on ClinicalTrials.gov

Treatment of Initial Clostridium Difficile Infection

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 1, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Clostridium Difficile Infection
Interventions
OTHER

FMT

Patients in the FMT group received FMT-FURM

DRUG

Vancomycin

Patients in the vancomycin group received oral vancomycin (250 mg every 6 h for 10-14 days)

All Listed Sponsors
lead

Universidad Autonoma de Nuevo Leon

OTHER

NCT03107169 - Treatment of Initial Clostridium Difficile Infection | Biotech Hunter | Biotech Hunter